Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros

Banco de datos
Tipo de estudio
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
J Liposome Res ; 19(3): 241-51, 2009.
Artículo en Inglés | MEDLINE | ID: mdl-19694606

RESUMEN

In this study, the mechanism of the internalization and the cellular distribution of 59 fluorescein conjugated PS-ODN (FITC-ODN) after transfection with different mixed lipidic vesicles/oligo complexes (lipoplexes) have been investigated. Mixed lipidic vesicles were prepared with one of the most used cationic lipid (DOTAP) and different amounts of a cholic acid (UDCA) to release the oligo into HaCaT cells. Using flow cytometry, the cellular uptake of the oligo was studied with and without different inhibitors able to block selectively the different pathways involved in the internalization mechanism. The intracellular distribution of the oligo was analyzed by confocal laser scanning microscopy (CLSM), treating the cells with the lipoplexes and directly observing without any fixing procedure. To better carry out the colocalization studies, fluorescent-labeled markers, specific for the different cellular compartments, were coincubated with 59 fluorescein-conjugated 29-mer phosphorotioate oligonucleotide (FITC-ODN). The different lipidic vesicles affect the internalization mechanism of FITC-ODN. After using the inhibitors, the uptake of complexes involved a different internalization mechanism. The live CLSM analysis demonstrated that, after 1 hour from the complex incubation, the oligo was transferred into cells and localized into the endosomes; after 24 hours, the oligo was intracellularly localized close to the nuclear structure in a punctuate pattern. However, the results from fusion experiments showed also a binding of a quite low amount of oligo with the cell membranes.


Asunto(s)
Línea Celular Tumoral/metabolismo , Citometría de Flujo/métodos , Fluoresceína , Microscopía Confocal/métodos , Oligodesoxirribonucleótidos , Animales , Portadores de Fármacos/química , Portadores de Fármacos/metabolismo , Fluoresceína/química , Fluoresceína/metabolismo , Humanos , Liposomas/química , Liposomas/metabolismo , Microscopía de Fuerza Atómica , Microscopía Electrónica de Transmisión , Oligodesoxirribonucleótidos/química , Oligodesoxirribonucleótidos/metabolismo
2.
J Mol Neurosci ; 25(2): 191-200, 2005.
Artículo en Inglés | MEDLINE | ID: mdl-15784967

RESUMEN

An interaction between adenosine A2A and dopamine D2 receptors has been demonstrated previously. It is generally found that agonist treatment internalizes receptors, including A2A and D2, whereas less is known of the long-term effects involved in the agonist-mediated trafficking of A2A and D2 receptors. Furthermore, the possible influence of the antagonists on receptor trafficking is still undefined. The present studies focus on the long-term effects of A2A and D2 agonist and D2 antagonist treatments on both A2A and D2 receptor trafficking studied at three different time intervals--3, 15, and 24 h. In addition, with the fluorescence resonance energy transfer technique, formation of heteromeric A2A and D2 receptor complexes was shown in the cotransfected CHO cell line. Confocal microscopy analysis showed that a 3-h treatment with the D2 agonist induced coaggregation of A2A/D2 receptors. These A2A/D2 receptor coaggregates internalized after 15 h with a recruitment of the receptors back to the cell membrane after 24 h. In contrast to the effects of the agonist treatment, a 3-h treatment with the D2-like antagonist raclopride increased both A2A and D2 immunoreactivity, indicating that the D2 antagonist stabilizes the D2 receptor and thereby reduces the internalization of both of the A2A and D2 receptors. Taken together, an activation of either A2A and D2 receptor or blockade of D2 receptors will cause long-lasting changes in A2A and D2 receptor trafficking.


Asunto(s)
Adenosina/análogos & derivados , Transporte de Proteínas/fisiología , Receptor de Adenosina A2A/metabolismo , Receptores de Dopamina D2/metabolismo , Adenosina/farmacología , Animales , Antihipertensivos/farmacología , Células CHO , Cricetinae , Perros , Agonistas de Dopamina/farmacología , Antagonistas de Dopamina/farmacología , Transferencia Resonante de Energía de Fluorescencia , Técnica del Anticuerpo Fluorescente , Humanos , Fenetilaminas/farmacología , Quinpirol/farmacología , Racloprida/farmacología , Receptor de Adenosina A2A/genética , Receptores de Dopamina D2/genética , Transfección
3.
Int J Nanomedicine ; 6: 557-63, 2011.
Artículo en Inglés | MEDLINE | ID: mdl-21468358

RESUMEN

An outstanding aspect of pharmaceutical nanotechnology lies in the characterization of nanocarriers for targeting of drugs and other bioactive agents. The development of microscopic techniques has made the study of the surface and systems architecture more attractive. In the field of pharmaceutical nanosystems, researchers have collected vital information on size, stability, and bilayer organization through the microscopic characterization of liposomes. This paper aims to compare the results obtained by atomic force microscopy, environmental scanning electron microscopy, transmission electron microscopy, and confocal laser scanning microscopy to point out the limits and advantages of these applications in the evaluation of vesicular systems. Besides this comparative aim, our work proposes a simple confocal laser scanning microscopy procedure to rapidly and easily detect the liposomal membrane.


Asunto(s)
Liposomas/ultraestructura , Microscopía Confocal/métodos , Nanotecnología/métodos , Microscopía de Fuerza Atómica , Microscopía Electrónica de Rastreo , Microscopía Electrónica de Transmisión , Tecnología Farmacéutica/métodos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA